At a glance
ClinicalIndex Comparison RecordN/ACompleted· 379 enrolled
Drug / intervention
Boston Scientific Ureteral Stents, Urinary Diversion Stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Boston Scientific Double-J PLUS Ureteral Stent Postmarket Patient Registry
In Brief
An observational study evaluating Boston Scientific Ureteral Stents, Urinary Diversion Stent for Ureter Obstruction. Completed, enrolled 379 participants across 10 sites in 4 countries.
Detailed Summary
A multi-center global registry to obtain post-market safety and efficacy data on Boston Scientific Ureteral and Urinary Diversion Stents
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUreter Obstruction
CountriesCanada, France, Japan, United States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedDec 2019
Enrollment StartFeb 2020
Primary CompletionJan 2023
Study CompletionFeb 2023
TodayJul 2026
First PostedDec 13, 2019
Enrollment StartFeb 19, 2020
Primary CompletionJan 16, 2023
Study CompletionFeb 22, 2023
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 6.6 years ago
Interventions
Boston Scientific Ureteral Stents, Urinary Diversion Stentdevice
A BSC Ureteral Stent is an implantable device that is used to restore flow of urine from the kidney to the bladder in obstructed ureters. A BSC Urinary Diversion Stent is an implantable device that is used to restore flow of urine from the kidney.